Skip to main content

Tempest Therapeutics, Inc.

TPST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001544227

No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.44M in total; no superinvestor holds it.

13F holders, Q2 2021

Institutional positions in Tempest Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
24
+24 vs. Q1 2021
Shares held
1.84M
+1.84M vs. Q1 2021
Total value
$20.5M
+$20.5M vs. Q1 2021
New holders
24
0 more added
Sold out
0
0 more reduced

Compare with Q1 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TPST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2021: 24 institutions
Q1 2021: 0 institutionsQ2 2021: 24 institutionsQ3 2021: 22 institutionsQ4 2021: 19 institutionsQ1 2022: 15 institutionsQ2 2022: 16 institutionsQ3 2022: 16 institutionsQ4 2022: 13 institutionsQ1 2023: 17 institutionsQ2 2023: 22 institutionsQ3 2023: 24 institutionsQ4 2023: 32 institutionsQ1 2024: 30 institutionsQ2 2024: 24 institutionsQ3 2024: 28 institutionsQ4 2024: 35 institutionsQ1 2025: 24 institutionsQ2 2025: 18 institutionsQ3 2025: 17 institutionsQ4 2025: 21 institutionsQ1 2026: 22 institutionsQ2 2026: 21 institutions
Value heldQ2 2021: $20.5M
Q1 2021: $0Q2 2021: $20.5MQ3 2021: $31.8MQ4 2021: $12.4MQ1 2022: $7.12MQ2 2022: $6.67MQ3 2022: $5.36MQ4 2022: $3.54MQ1 2023: $8.72MQ2 2023: $4.86MQ3 2023: $1.05MQ4 2023: $9.88MQ1 2024: $7.58MQ2 2024: $4.70MQ3 2024: $3.94MQ4 2024: $5.66MQ1 2025: $4.42MQ2 2025: $6.42MQ3 2025: $6.02MQ4 2025: $2.26MQ1 2026: $1.29MQ2 2026: $1.44M
Institutions holding TPST and their total value by quarter
QuarterHoldersValue
Q2 202621$1.44M
Q1 202622$1.29M
Q4 202521$2.26M
Q3 202517$6.02M
Q2 202518$6.42M
Q1 202524$4.42M
Q4 202435$5.66M
Q3 202428$3.94M
Q2 202424$4.70M
Q1 202430$7.58M
Q4 202332$9.88M
Q3 202324$1.05M
Q2 202322$4.86M
Q1 202317$8.72M
Q4 202213$3.54M
Q3 202216$5.36M
Q2 202216$6.67M
Q1 202215$7.12M
Q4 202119$12.4M
Q3 202122$31.8M
Q2 202124$20.5M
Q1 20210$0

Institutions, Q2 2021

Shares, value and share of portfolio for each institution holding Tempest Therapeutics, Inc.; share changes are against Q1 2021.

Institutions holding TPST in Q2 2021
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC647,898$7.24M0.00%+647,898New
Rock Springs Capital Management LP310,161$3.47M0.07%+310,161New
Foresite Capital Management IV, LLC190,212$2.13M0.29%+190,212New
FIL Ltd129,579$1.45M0.00%+129,579New
NEA Management Company, LLC117,785$1.32M0.02%+117,785New
Monashee Investment Management LLC113,644$1.27M0.15%+113,644New
Maven Securities LTD106,628$1.20M0.13%+106,628New
Ikarian Capital, LLC89,865$1.00M0.18%+89,865New
Vanguard Group Inc61,150$683.0K0.00%+61,150New
Renaissance Technologies LLC26,867$300.0K0.00%+26,867New
Knott David M13,833$155.0K0.06%+13,833New
Boothbay Fund Management, LLC10,477$117.0K0.00%+10,477New
Acadian Asset Management LLC8,643$96.0K0.00%+8,643New
BlackRock Inc.4,919$55.0K0.00%+4,919New
Bank of America Corp834$9.00K0.00%+834New
Group One Trading, L.P.802$9.00K0.00%+802New
Morgan Stanley726$8.00K0.00%+726New
Tower Research Capital LLC (TRC)583$6.00K0.00%+583New
Cutler Group LP333$3.00K0.00%+333New
UBS Group AG147$2.00K0.00%+147New
JPMorgan Chase & Co10$00.00%+10New
Wells Fargo & Company8$00.00%+8New
Baystate Wealth Management LLC5$00.00%+5New
Atlas Private Wealth Advisors7$00.00%+7New